- Login
- Register & Subscribe
- Language: EN FR DE
Regenerative Medicine
UK awards £8.5 million to regenerative medicine projects
Tuesday 6 December 2011
Fourteen research and development projects in the field of regenerative medicine are set to receive £8.5 million from the UK government as part of a drive to stimulate innnovation in the sector. The projects will be led by small and medium sized companies.
Location
United Kingdom
Interim results of cardiac stem cell trial said encouraging
Sunday 4 December 2011
A team of US scientists has reported interim results from a Phase 1 study of an autologous cardiac stem cell therapy which showed a substantial improvement in left ventricular systolic function in patients with heart disease. The findings appear in The Lancet.
Location
United States
Geron abandons stem cells
Wednesday 16 November 2011
Geron Corporation, which launched the first human study of an embryonic stem cell therapy in the west, has decided to leave the stem cell field citing the unfavourable financial environment. It is stopping its trial in patients with spinal cord injury.
Location
United States
Fibrin sealant meets primary endpoint in Phase 2 trial
Tuesday 15 November 2011
A sealant that has been developed to stop bleeding during and after surgery has met its primary endpoint in a Phase 2 trial of patients undergoing liver resection surgery, according to the developer, ProFibrix BV of the Netherlands.
Location
Netherlands
FDA approves first cord blood product
Thursday 10 November 2011
The US Food and Drug Administration has approved the first haematopoietic progenitor cell-cord cell therapy. Called Hemacord, the product is manufactured by the New York Blood Center Inc of New York.
Location
United States
TiGenix gives update on cell therapy
Thursday 3 November 2011
TiGenix NV said that group revenues for the first nine months of 2011 were €1.1 million of which the majority was generated by the company’s cell-based therapy to treat knee injuries, ChondroCelect. Cash at 30 September 2011 was €20.5 million.
Location
Belgium
European court rules against stem cell patents in research
Tuesday 18 October 2011
In a decision that will have far-reaching consequences for regenerative medicine, the European Court of Justice has ruled that inventions requiring the destruction of human embryos, or their prior use as base material, cannot be patented under European law if the purpose is purely for scientific research.
Location
Luxembourg
NeoStem acquires cell therapy company
Monday 17 October 2011
NeoStem Inc of New York, which has a business in adult stem cell collection and storage, has completed an all-share acquisition of Amorcyte Inc of New Jersey in a bid to develop a portfolio of therapies based on stem-cell technology.
Location
United States
ECJ to rule on stem cell patents
Monday 10 October 2011
The European Court of Justice is scheduled to issue a judgment on 18 October 2011 in a case concerning the patentability of technology based on the use of human embryonic stem cells. The case involves a German researcher, Oliver Brüstle.
Location
Luxembourg
Scientists derive stem cells from cloned embryo
Friday 7 October 2011
A team of US scientists has used cloning technology to create embryos from the skin cells of diabetic patients, and then derived stem cells from these embryos. This is thought to be the first such procedure using patient-specific cells.
Location
United States
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013